The mortality rate of dermatomyositis is estimated to be 10% and is especially high in the first year of the disease.

- Advanced age

- Initiation of treatment more than six months following the onset of symptoms

- Severe muscle weakness on presentation

- Presence of dysphagia

- Pulmonary involvement in the form of respiratory muscle weakness or interstitial lung disease

- Cardiac involvement

- Underlying malignancy

Sixty-five percentÂ of patients who survive have normal strength, 34% have a mild disability, and 16% have no disability. With treatment, 20% of patients attain remission, whereas 80% have a chronic or polycyclic course.